Aperture Healthcare Ventures Ltd. 3
3 · Chromocell Therapeutics Corp · Filed Feb 15, 2024
Insider Transaction Report
Form 3
Aperture Healthcare Ventures Ltd.
10% Owner
Holdings
- 426,566
Common Stock
Senior Secured Convertible Promissory Note
Exp: 2024-02-29→ Common Stock (11,532 underlying)Senior Secured Convertible Promissory Note
Exp: 2024-03-01→ Common Stock (5,965 underlying)
Footnotes (3)
- [F1]Represents $55,371.91 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which will automatically convert into 11,536 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering.
- [F2]Represents $28,282.11 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due March 1, 2024, which will automatically convert into 5,968 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, including an additional 75 shares of common stock issuable as consideration for this senior secured convertible promissory note.
- [F3]Avi Wachsman has sole voting and dispositive power over the shares held by the Reporting Person as to which Mr. Wachsman disclaims beneficial ownership except to the extent of his pecuniary interest therein.